| |
| |
|
| Insider
Information: |
Frost Gamma Investment Trust |
| Relationship: |
10% Owner |
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
21 |
|
| Direct
Shares |
29,899,368 |
|
|
Indirect Shares
|
470,601,801 |
|
|
| Direct
Value |
$79,911,306 |
|
|
|
Indirect Value
|
$597,534,720 |
|
|
| Total
Shares |
500,501,169 |
|
|
| Total
Value |
$677,446,026 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
98
|
0
|
|
Stock
price went up :
|
54
|
0
|
| Stock
price went down : |
44
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.2
|
0.0
|
| Percentage
Gain/Loss : |
 40.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dreams Inc |
DRJ |
10% Owner |
2009-12-24 |
0 |
2009-12-24 |
5,128,205 |
Premium* |
|
|
Protalix Biotherapeutics |
PLX |
10% Owner |
2006-12-31 |
0 |
2009-09-10 |
7,610,167 |
Premium* |
|
|
Opko Health Inc |
OPK |
|
2024-03-18 |
3,068,951 |
2024-03-18 |
241,095,402 |
Premium* |
|
|
Prolor Biotech Inc |
PBTH |
10% Owner |
2012-12-28 |
0 |
2013-08-29 |
0 |
Premium* |
|
|
Ladenburg Thalmann Financial Ser... |
LTS |
10% Owner |
2007-08-13 |
0 |
2009-03-31 |
51,785,730 |
Premium* |
|
|
Asensus Surgical Inc |
ASXC |
10% Owner |
2007-08-13 |
0 |
2013-12-06 |
20,542,346 |
Premium* |
|
|
Continucare Corp |
CNU |
10% Owner |
2008-12-15 |
400,000 |
2008-12-15 |
25,590,917 |
Premium* |
|
|
Tiger X Medical Inc |
CDOM |
10% Owner |
|
0 |
2024-01-19 |
1,896,025 |
Premium* |
|
|
Northrop Grumman Corp |
NOC |
Trust |
2008-08-05 |
12,357 |
2008-08-05 |
70,525 |
Premium* |
|
|
Winston Pharmaceuticals Inc |
WPHM |
10% Owner |
2008-09-25 |
0 |
2010-05-19 |
0 |
Premium* |
|
|
Castle Brands Inc |
ROX |
10% Owner |
2009-03-31 |
599,776 |
2009-03-31 |
29,907,769 |
Premium* |
|
|
Fluent Inc |
FLNT |
Joint Filer |
2023-09-19 |
50,000 |
2023-09-19 |
18,834,874 |
Premium* |
|
|
Non Invasive Monitoring Systems ... |
NIMU |
10% Owner |
2009-12-24 |
0 |
2019-01-24 |
54,690,325 |
Premium* |
|
|
ChromaDex Corporation |
CDXC |
10% Owner |
2013-12-30 |
0 |
2013-12-30 |
5,852,937 |
Premium* |
|
|
Alliqua BioMedical Inc |
ALQA |
10% Owner |
2012-03-28 |
25,761,618 |
|
0 |
Premium* |
|
|
Pershing Gold Corp. |
PGLC |
10% Owner |
2016-05-09 |
0 |
|
0 |
Premium* |
|
|
Cocrystal Pharma |
COCP |
10% Owner |
|
0 |
2023-04-04 |
1,319,838 |
Premium* |
|
|
Eloxx Pharmaceuticals Inc |
ELOX |
10% Owner |
2014-05-16 |
0 |
2015-09-29 |
1,598,170 |
Premium* |
|
|
Red Violet Inc |
RDVT |
10% Owner |
2020-12-17 |
6,666 |
2020-12-17 |
0 |
Premium* |
|
|
Great West Resouces |
SILVD |
10% Owner |
|
0 |
2023-04-11 |
3,428,571 |
Premium* |
|
|
Nocopi Technologies Inc /md/ |
NNUP |
10% Owner |
|
0 |
2023-09-11 |
1,250,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2009-02-23 |
4 |
A |
$1.00 |
$20,000,000 |
I/I |
20,000,000 |
92,041,842 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2007-12-04 |
4 |
B |
$1.84 |
$12,449,999 |
I/I |
6,766,304 |
47,801,157 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2011-03-09 |
4 |
A |
$3.75 |
$12,000,000 |
I/I |
3,200,000 |
103,517,052 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2008-08-08 |
4 |
A |
$1.11 |
$11,852,253 |
I/I |
10,677,705 |
70,302,352 |
0 |
- |
|
| CDOM |
Tiger X Medical Inc |
10% Owner |
– – • |
2016-05-10 |
4 |
B |
$0.10 |
$11,493,715 |
I/I |
114,937,148 |
149,734,604 |
1.5 |
- |
|
| PGLC |
Pershing Gold Corp. |
10% Owner |
– – • |
2016-05-09 |
4 |
S |
$3.65 |
$11,086,397 |
D/D |
(3,037,369) |
0 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2015-01-31 |
4 |
D |
$11.62 |
$10,668,216 |
I/I |
(906,146) |
20,091,062 |
0 |
- |
|
| FLNT |
Fluent Inc |
Joint Filer |
– – – |
2016-05-09 |
4 |
B |
$4.80 |
$10,512,000 |
I/I |
2,190,000 |
15,607,973 |
0.01 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2011-10-04 |
4 |
B |
$3.60 |
$8,827,999 |
I/I |
2,452,222 |
108,285,187 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2017-05-10 |
4 |
B |
$6.96 |
$7,829,775 |
I/I |
1,125,000 |
162,411,643 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2015-08-06 |
4 |
OE |
$7.07 |
$7,423,295 |
I/I |
1,049,971 |
156,015,068 |
0 |
- |
|
| OPK |
Opko Health Inc |
10% Owner |
– – • |
2007-07-13 |
4 |
B |
$1.80 |
$7,291,452 |
D/D |
4,042,060 |
40,589,183 |
2.45 |
- |
|
| OPK |
Opko Health Inc |
CEO &Chairman |
– – • |
2008-02-13 |
4 |
B |
$1.80 |
$6,865,200 |
I/I |
3,814,000 |
54,714,296 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2015-08-20 |
4 |
B |
$12.32 |
$6,702,134 |
I/I |
544,000 |
156,559,068 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2013-12-13 |
4 |
OE |
$1.16 |
$6,577,500 |
D/D |
1,987,500 |
1,987,500 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2015-08-07 |
4 |
OE |
$2.36 |
$5,878,686 |
D/D |
1,056,574 |
3,068,951 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2015-01-31 |
4 |
OE |
$0.00 |
$5,712,275 |
I/I |
14,786,430 |
20,286,704 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2008-02-11 |
4 |
B |
$1.80 |
$5,306,650 |
I/I |
2,948,139 |
50,900,296 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2011-01-21 |
4 |
B |
$3.45 |
$4,109,943 |
I/I |
1,158,000 |
99,387,052 |
1.5 |
- |
|
| PBTH |
Prolor Biotech Inc |
10% Owner |
– – • |
2010-05-20 |
4 |
OE |
$0.50 |
$3,368,417 |
I/I |
4,948,417 |
11,484,083 |
0 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2008-05-08 |
4 |
B |
$1.25 |
$3,291,500 |
I/I |
2,633,200 |
58,350,044 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2011-03-09 |
4 |
B |
$3.53 |
$3,240,029 |
I/I |
900,000 |
100,317,052 |
1.5 |
- |
|
| COCP |
Cocrystal Pharma |
10% Owner |
– – • |
2015-03-25 |
4 |
B |
$0.92 |
$3,187,667 |
I/I |
3,464,855 |
103,558,969 |
1.5 |
- |
|
| OPK |
Opko Health Inc |
CEO & Chairman |
– – • |
2019-10-25 |
4 |
B |
$1.50 |
$3,000,000 |
I/I |
2,000,000 |
166,234,443 |
1.5 |
- |
|
| PLX |
Protalix Biotherapeutics |
10% Owner |
– – • |
2007-01-31 |
4 |
OE |
$1.38 |
$2,968,448 |
I/I |
2,157,302 |
9,766,273 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
